{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:39:28Z","timestamp":1778837968900,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/aps.2017.200","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T10:00:39Z","timestamp":1523527239000},"page":"1473-1482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteomics analysis reveals a potential new target protein for the lipid-lowering effect of Berberine8998"],"prefix":"10.1038","volume":"39","author":[{"given":"Cheng-yin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang-yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-zhou","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darek C","family":"Gorecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmita V","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"135_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/187153008784534330","volume":"8","author":"J Yin","year":"2008","unstructured":"Yin J, Zhang H, Ye J. Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets 2008; 8: 99\u2013111.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"135_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","volume":"243","author":"A Pirillo","year":"2015","unstructured":"Pirillo A, Catapano AL. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis 2015; 243: 449\u201361.","journal-title":"Atherosclerosis"},{"key":"135_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1135","volume":"10","author":"W Kong","year":"2004","unstructured":"Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10: 1344\u201351.","journal-title":"Nat Med"},{"key":"135_CR4","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1016\/j.bmc.2010.06.085","volume":"18","author":"Z Cheng","year":"2010","unstructured":"Cheng Z, Chen AF, Wu F, Sheng L, Zhang HK, Gu M, et al. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. Bioorg Med Chem 2010; 18: 5915\u201324.","journal-title":"Bioorg Med Chem"},{"key":"135_CR5","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1016\/j.bmc.2010.06.106","volume":"18","author":"YH Li","year":"2010","unstructured":"Li YH, Li Y, Yang P, Kong WJ, You XF, Ren G, et al. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg Med Chem 2010; 18: 6422\u20138.","journal-title":"Bioorg Med Chem"},{"key":"135_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jama.290.7.947","volume":"290","author":"JG Canto","year":"2003","unstructured":"Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the \"only 50%\" myth. JAMA 2003; 290: 947\u20139.","journal-title":"JAMA"},{"key":"135_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature06796","volume":"451","author":"DJ Rader","year":"2008","unstructured":"Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008; 451: 904\u201313.","journal-title":"Nature"},{"key":"135_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317\u201325.","journal-title":"Nature"},{"key":"135_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1194\/jlr.M800375-JLR200","volume":"50","author":"H Li","year":"2009","unstructured":"Li H, Chen W, Zhou Y, Abidi P, Sharpe O, Robinson WH, et al. Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements. J Lipid Res 2009; 50: 820\u201331.","journal-title":"J Lipid Res"},{"key":"135_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-2004-822993","volume":"4","author":"JC Defesche","year":"2004","unstructured":"Defesche JC. Low-density lipoprotein receptor--its structure, function, and mutations. Semin Vasc Med 2004; 4: 5\u201311.","journal-title":"Semin Vasc Med"},{"key":"135_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/41798","volume":"388","author":"D Fass","year":"1997","unstructured":"Fass D, Blacklow S, Kim PS, Berger JM. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 1997; 388: 691\u20133.","journal-title":"Nature"},{"key":"135_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.biochem.74.082803.133354","volume":"74","author":"H Jeon","year":"2005","unstructured":"Jeon H, Blacklow SC. Structure and physiologic function of the low-density lipoprotein receptor. Annu Rev Biochem 2005; 74: 535\u201362.","journal-title":"Annu Rev Biochem"},{"key":"135_CR13","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1074\/jbc.M116.763532","volume":"292","author":"J Zeng","year":"2017","unstructured":"Zeng J, Deng S, Wang Y, Li P, Tang L, Pang Y. Specific inhibition of Acyl-CoA Oxidase-1 by an acetylenic acid improves hepatic lipid and reactive oxygen species (ROS) metabolism in rats fed a high fat diet. J Biol Chem 2017; 292: 3800\u20139.","journal-title":"J Biol Chem"},{"key":"135_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jprot.2013.12.011","volume":"101","author":"LP Kristensen","year":"2014","unstructured":"Kristensen LP, Larsen MR, Mickley H, Saaby L, Diederichsen AC, Lambrechtsen J, et al. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. J Proteomics 2014; 101: 141\u201353.","journal-title":"J Proteomics"},{"key":"135_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/pmic.201000460","volume":"11","author":"S Ray","year":"2011","unstructured":"Ray S, Reddy PJ, Jain R, Gollapalli K, Moiyadi A, Srivastava S. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011; 11: 2139\u201361.","journal-title":"Proteomics"},{"key":"135_CR16","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1210\/jc.2007-2404","volume":"93","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008; 93: 2559\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"135_CR17","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jprot.2012.03.010","volume":"75","author":"HC Chou","year":"2012","unstructured":"Chou HC, Lu YC, Cheng CS, Chen YW, Lyu PC, Lin CW, et al. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics 2012; 75: 3158\u201376.","journal-title":"J Proteomics"},{"key":"135_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/pr3010259","volume":"12","author":"Q Hou","year":"2013","unstructured":"Hou Q, Tan HT, Lim KH, Lim TK, Khoo A, Tan IB, et al. Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein. J Proteome Res 2013; 12: 980\u201390.","journal-title":"J Proteome Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2017200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017200","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:36:13Z","timestamp":1684413373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2017200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.200","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}